Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.
Gaucher disease, a prevalent lysosomal storage disease, is caused by insufficient activity of acid β-glucosidase (GCase) and resultant glucosylceramide accumulation. Recently in Parkinson disease (PD) patients, heterozygous mutations in GCase have been associated with earlier onset and more progressive PD. To understand the pathogenic relationships between GCase variants and Parkinsonism, α-synuclein and ubiquitin distributions and levels in the brains of several mouse models containing GCase variants were evaluated by immunohistochemistry. Progressive α-synuclein and ubiquitin aggregate accumulations were observed in the cortex, hippocampus, basal ganglia, brainstem, and some cerebellar regions between 4 and 24 weeks in mice that were homozygous for GCase [D409H (9H) or V394L (4L)] variants and also had a prosaposin hypomorphic (PS-NA) transgene. In 4L/PS-NA and 9H/PS-NA mice, this was coincident with progressive neurological manifestations and brain glucosylceramide accumulation. Ultrastructural studies showed electron dense inclusion bodies in neurons and axons of 9H/PS-NA brains. α-synuclein aggregates were also observed in ventricular, brainstem, and cerebellar regions of older mice (>42-weeks) with the GCase variant (D409H/D409H) without overt neurological disease. In a chemically induced GCase deficiency, α-synuclein aggregates and glucosylceramide accumulation also occurred. These studies demonstrate a relationship between glucosylceramide accumulation and α-synuclein aggregates, and implicate glucosylceramide accumulation as risk factor for the α-synucleinopathies.
Division of Human Genetics, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA.
Y H
YH
Xu
Y
Y
Sun
H
H
Ran
B
B
Quinn
D
D
Witte
G A
GA
Grabowski
D000367:Age Factors; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology*; D004195:Disease Models, Animal; D005776:Gaucher Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D005963:Glucosylceramides / Q000378:metabolism; D002479:Inclusion Bodies / Q000473:pathology; D007294:Inositol / Q000031:analogs & derivatives / Q000494:pharmacology; D051379:Mice; D020125:Mutation, Missense; D010641:Phenotype; D011609:Psychosine / Q000031:analogs & derivatives / Q000378:metabolism; D025801:Ubiquitin / Q000378:metabolism*; D051844:alpha-Synuclein / Q000378:metabolism*; D001617:beta-Glucosidase / Q000235:genetics / Q000378:metabolism
D005963:Glucosylceramides; D025801:Ubiquitin; D051844:alpha-Synuclein; D011609:Psychosine; D007294:Inositol; C035742:sphingosyl beta-glucoside; D001617:beta-Glucosidase; C011423:conduritol epoxide
Science. 1997 Jun 27;276(5321):2045-7
9197268
Acta Neuropathol. 1984;65(2):99-109
6524300
Nature. 1997 Aug 28;388(6645):839-40
9278044
Brain Res. 2008 Jan 10;1188:241-53
18022143
Medicine (Baltimore). 1992 Nov;71(6):337-53
1435229
Acta Neuropathol. 2005 Sep;110(3):255-60
16003542
Annu Rev Neurosci. 2005;28:57-87
16022590
Nat Rev Neurosci. 2005 Sep;6(9):713-25
16049428
J Neuropathol Exp Neurol. 2001 Jan;60(1):49-64
11202175
Hum Mol Genet. 1996 Jun;5(6):711-25
8776585
J Biol Chem. 2004 Jun 18;279(25):26167-75
15078881
Acta Neuropathol. 1998 Jul;96(1):29-40
9678511
J Biol Chem. 2003 Aug 22;278(34):31918-23
12813057
Ann Neurol. 1986 Aug;20(2):223-30
3752966
Neurology. 2006 Sep 12;67(5):908-10
16790605
Am J Med Genet A. 2003 Feb 1;116A(4):348-51
12522789
Am J Hum Genet. 1993 Jun;52(6):1094-101
8503443
J Biol Chem. 1999 Jul 9;274(28):19509-12
10391881
Autophagy. 2008 Jan;4(1):113-4
18000397
J Pathol. 2003 May;200(1):95-103
12692847
Mol Genet Metab. 2008 Jun;94(2):190-203
18346921
Neuropharmacology. 2003 Jul;45(1):14-44
12814657
N Engl J Med. 2009 Oct 22;361(17):1651-61
19846850
Nat Genet. 1998 Feb;18(2):106-8
9462735
Nat Rev Mol Cell Biol. 2004 Jul;5(7):554-65
15232573
J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):172-5
3981177
Mol Genet Metab. 2004 Jan;81(1):70-3
14728994
J Neurosci Methods. 1999 Feb 1;87(1):111-5
10066000
J Neurosci Res. 2000 Jul 15;61(2):121-7
10878583
Nature. 2006 Oct 19;443(7113):780-6
17051204
Hum Mol Genet. 1998 Sep;7(9):1347-54
9700186
Mol Genet Metab. 2003 Jun;79(2):104-9
12809640
Mol Genet Metab. 2007 Jun;91(2):195-200
17462935
Science. 2000 Feb 18;287(5456):1265-9
10678833
Hum Mol Genet. 2008 Aug 1;17(15):2345-56
18480170
Hum Mol Genet. 2010 Feb 15;19(4):634-47
20015957
Neuron. 2000 Jan;25(1):239-52
10707987
Nature. 2006 Jun 15;441(7095):880-4
16625205
J Lipid Res. 2010 Jul;51(7):1643-75
20211931
Brain. 2002 Jan;125(Pt 1):44-57
11834592
Science. 1997 Jul 11;277(5323):232-5
9211850
Lancet Neurol. 2004 Aug;3(8):496-503
15261611
J Med Genet. 2004 Dec;41(12):937-40
15591280
Crit Rev Oncol Hematol. 1996 May;23(1):25-55
8817081
Clin Genet. 1998 May;53(5):349-61
9660052
J Neurosci. 2000 Sep 1;20(17):6365-73
10964942
Nature. 2006 Jun 15;441(7095):885-9
16625204
Hum Mol Genet. 2004 Nov 1;13(21):2709-23
15345707
Am J Hematol. 1999 Jul;61(3):216-7
10398575
J Lipid Res. 2005 Oct;46(10):2102-13
16061944
J Neurosci. 2002 Apr 1;22(7):2780-91
11923443
Neurology. 1969 Feb;19(2):133-40
5812606
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1661-8
16449387
Arch Pathol. 1967 Jun;83(6):513-26
6024729
Acta Neuropathol. 1991;82(2):152-7
1718128
Neuroreport. 2003 Mar 24;14(4):551-4
12657883
Am J Pathol. 2003 Nov;163(5):2093-101
14578207
Hum Mol Genet. 2001 May 15;10(11):1191-9
11371512
J Pathol Bacteriol. 1956 Jul;72(1):121-31
13367986
Blood Cells Mol Dis. 2006 May-Jun;36(3):426-8
16651014
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571-6
10639120
J Biol Chem. 1986 Jun 25;261(18):8263-9
3087971
Mol Genet Metab. 2002 Aug;76(4):271-86
12208132
Brain. 2006 Jan;129(Pt 1):256-71
16246864
Hum Mol Genet. 1997 Apr;6(4):503-11
9097952
Biochem Biophys Res Commun. 1975 Nov 3;67(1):85-90
1239284
Acta Neuropathol. 2010 Nov;120(5):641-9
20838799
Ann N Y Acad Sci. 1998 Jun 19;845:139-51
9668348
Mol Genet Metab. 2004 Jul;82(3):192-207
15234332
Neurology. 2009 Jan 27;72(4):310-6
18987351